期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

类风湿关节炎患者淋巴细胞协同刺激分子和活化标志的表达及意义 被引量：2

原文传递
导出
作者 冷建杭 韩阳 卓广超 王克义 汪子伟 彭亮 张玉芳
机构地区 杭州市第一人民医院中心实验室 浙江大学医学院附属第一医院国际保健体检中心
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第2期189-190,共2页 Chinese Journal of Laboratory Medicine
基金 杭州市医药卫生科技研究基金资助项目(01A013)
关键词 淋巴细胞 RA 活化标志 协同刺激分子 类风湿关节炎 患者 表达 纤维母细胞 诊断和治疗 发现
分类号 R593.22 [医药卫生—内科学] R392 [医药卫生—免疫学]
  • 相关文献

参考文献6

  • 1Skapenko A, Lipsky PE, Kraetsch HG, et al. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J Immunol, 2001, 166:4283-4296.
  • 2Caruso A, Licenziafi S, CoruUi M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry, 1997, 27:71-76.
  • 3Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 cestimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol, 2001, 19:225-252.
  • 4Kuchroo VK, Daa MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy.Cell, 1995, 80:707-718.
  • 5Kitagawa M, Mitsui H, Nakamura H, et al. Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals. Arthritis Rheum, 1999, 42: 1971-1976.
  • 6冷建杭,蒋群芳,姜晓虹,卓广超,王克义,汪子伟.类风湿关节炎血清和滑液Th1/Th2细胞因子的水平及意义[J].浙江临床医学,2004,6(6):457-458. 被引量：6

二级参考文献8

  • 1[1]Santana MA, Rosenstein Y. What it takes to become an effector T cell:the process, the cells involved, and the mechanisms. J Cell Physiol,2003,195(3) :392 ～ 401.
  • 2[2]Elewaut D, Keyser FD, Wever ND, et al. A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis,1998,57(8) :480 ～ 486.
  • 3[3]Kanik KS, Hagiwara E, Yarboro CH, et al. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol, 1998, 25(1): 16～ 22.
  • 4[4]Racke MK, Bonomo A. Cytokine - induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med, 1994, 180(8): 1961 ～ 1966.
  • 5[5]Simon AK, Seipelt E, Seiper J. Divergent T- cell Cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA, 1994, 91(7):8562～8566.
  • 6[6]Paludan SR. Interleukin - 4 and interferon - gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol, 1998, 48(5):459 ～ 468.
  • 7[7]Whalen JD, Lechman EL, Carlos CA, aeyet al. Adenoviral tranfer of the viral IL- 10 gene periarticularly to mouse paws suppresses development of collagen - induced arthritis in both injected and uninjected paws. J Immunol, 1999,162(6) :3625 ～ 3632.
  • 8[8]Joosten LA, Lubberts E, Durez P, et al. Role of interleukin - 4 and interleukin - 10 in murine collagen-induced arthritis: protective effect of interleukin - 4 and interleukin - 10 treatment on cartilage destruction.Arthritis Rheum, 1997,40(2) :249 ～ 260.

共引文献5

同被引文献17

  • 1姚咏明.免疫功能紊乱在脓毒症发病中的作用及意义[J].中国危重病急救医学,2007,19(3):138-141. 被引量：63
  • 2Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29(7):1303-1310.
  • 3Mant TG,Borozdenkova S,Bradford DB,et al.Changes in HLA-DR expression,cytokine production and coagulation following endotoxin infusion in healthy human volunteers,Int Immunophramacol,2008,8(5):701-707.
  • 4Bone RC.Sir Isaac Newton,sepsis,SIRS,and CARS.Crit Care Med,1996,24(7):1125-1128.
  • 5Hynninen M,Pettila V,Takkunen O,et al.Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and-10 levels in critically ill patients with sepsis.Shock,2003,20(1):1-4.
  • 6Lekkou A,Karakantza M,Mouzaki A,et al.Cytokiue production and manocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.Clin Diagn Lab Immunol,2004,11 (1):161-167.
  • 7Angus DC, Linde- Zwirble, WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001, 29(7) :1303 -1310.
  • 8Mant TG, Borozdenkova S. Bradford DB, et al. Changes in HLA - DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers [J].Int Immunopharmacol, 2008, 8(5) :701 -107.
  • 9Monneret G, Venet F. Statins and sepsis: Do we really need to further decrease monocyte HLA - DR expression to treat septic patients [ J ]. Lancet Infect Dis, 2007, 7( 11 ) :697 -699.
  • 10Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation[J]. Cytometry, 1997, 27(1) :71 -76.

引证文献2

二级引证文献5

中华检验医学杂志
2005年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部